Literature DB >> 15167354

Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid.

Charles T Quinn1, James C Griener, Teodoro Bottiglieri, Erland Arning, Naomi J Winick.   

Abstract

Methotrexate (MTX) is an antifolate that affects many metabolic pathways. MTX may cause neurologic toxicity, but the biochemical effects of MTX on the central nervous system (CNS) are poorly characterized. The authors studied serial cerebrospinal fluid (CSF) samples from a child during two courses of intraventricular MTX and found a rapid and reproducible depletion in CSF of reduced folates and S-adenosylmethionine that was accompanied by marked increases in homocysteine and adenosine. No sulfur-containing excitatory amino acids were detected. This study demonstrates multiple profound effects of MTX on CNS metabolism and provides insight to the pathogenesis of MTX neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15167354     DOI: 10.1097/00043426-200406000-00011

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

1.  History of the biomedical studies PhD program: a joint graduate program of the Baylor Health Care system and Baylor University.

Authors:  Christine R Morel; Joshua M Horton; Han Peng; Kangling Xu; Sushil K Batra; Jonathan P Miles; Robert R Kane
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

2.  Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.

Authors:  Michael Linnebank; Susanna Moskau; Annika Jürgens; Matthias Simon; Alexander Semmler; Katjana Orlopp; Axel Glasmacher; Christopher Bangard; Marlies Vogt-Schaden; Horst Urbach; Ingo G H Schmidt-Wolf; Hendrik Pels; Uwe Schlegel
Journal:  Neuro Oncol       Date:  2008-09-19       Impact factor: 12.300

3.  Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.

Authors:  Kala Y Kamdar; Kevin R Krull; Randa A El-Zein; Pim Brouwers; Brian S Potter; Lynnette L Harris; Suzanne Holm; Zoann Dreyer; Fernando Scaglia; Carol J Etzel; Melissa Bondy; M Fatih Okcu
Journal:  Pediatr Blood Cancer       Date:  2011-05-25       Impact factor: 3.167

4.  Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.

Authors:  Zahra Mansouri; Masoumeh Sabetkasaei; Fatemeh Moradi; Fatemeh Masoudnia; Amin Ataie
Journal:  J Mol Neurosci       Date:  2012-03-15       Impact factor: 3.444

5.  The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester.

Authors:  Ertugrul Uzar; Hasan Rifat Koyuncuoglu; Efkan Uz; H Ramazan Yilmaz; Suleyman Kutluhan; Serkan Kilbas; Fatih Gultekin
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

6.  Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites.

Authors:  R Ackermann; A Semmler; G D Maurer; E Hattingen; F Fornoff; J P Steinbach; M Linnebank
Journal:  J Neurooncol       Date:  2009-10-11       Impact factor: 4.130

7.  The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series.

Authors:  Andrea Santangelo; Emanuele Bartolini; Giulia Nuzzi; Thomas Foiadelli; Alexandre Michev; Tommaso Mina; Irene Trambusti; Valeria Fichera; Alice Bonuccelli; Gabriele Massimetti; Diego G Peroni; Emanuela De Marco; Luca Coccoli; Laura Luti; Sayla Bernasconi; Margherita Nardi; Maria Cristina Menconi; Gabriella Casazza; Dario Pruna; Rosamaria Mura; Chiara Marra; Daniele Zama; Pasquale Striano; Duccio M Cordelli; Roberta Battini; Alessandro Orsini
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.